CLINICAL_TRIALS
trial_result
· 2021-11-09
Clinical Trial Update: Validation Study for the Alertgy Non-invasive Continuous Glucose Monitor (ANICGM)
Summary
A completed validation study for the Alertgy Non-invasive Continuous Glucose Monitor (ANICGM) conducted by The Cleveland Clinic; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Cleveland Clinic | Conditions: Type 2 Diabetes | Status: COMPLETED | Results posted: 2021-11-09